for the Period Ended 31 July 2025
| Profit and loss | |
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
for the Period Ended
| 2025 | 2024 | |
|---|---|---|
|
|
£ |
£ |
| Turnover: |
|
|
| Cost of sales: |
|
|
| Gross profit(or loss): |
|
|
| Distribution costs: |
|
|
| Administrative expenses: |
(
|
(
|
| Other operating income: |
|
|
| Operating profit(or loss): |
|
|
| Interest receivable and similar income: |
|
|
| Interest payable and similar charges: |
|
|
| Profit(or loss) before tax: |
|
|
| Tax: |
|
|
| Profit(or loss) for the financial year: |
|
|
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Fixed assets | |||
| Intangible assets: |
|
|
|
| Tangible assets: |
|
|
|
| Investments: |
|
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Stocks: |
|
|
|
| Debtors: |
|
|
|
| Cash at bank and in hand: |
|
|
|
| Investments: |
|
|
|
| Total current assets: |
|
|
|
| Prepayments and accrued income: |
|
|
|
| Creditors: amounts falling due within one year: | 3 |
(
|
|
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Creditors: amounts falling due after more than one year: |
|
|
|
| Provision for liabilities: |
|
|
|
| Accruals and deferred income: |
|
|
|
| Total net assets (liabilities): |
|
|
|
| Members' funds | |||
| Profit and loss account: |
|
|
|
| Total members' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 July 2025
Basis of measurement and preparation
Valuation information and policy
for the Period Ended 31 July 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 31 July 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Bank loans and overdrafts |
|
|
| Amounts due under finance leases and hire purchase contracts |
|
|
| Trade creditors |
|
|
| Taxation and social security |
|
|
| Accruals and deferred income |
|
|
| Other creditors |
|
|
| Total |
|
|
The Nerve of My Multiple Sclerosis CIC supports and advocates for Black people living with neurological autoimmune conditions, including Multiple Sclerosis, NMOSD and MOGAD, with a particular focus on Black women and Black girls. During the financial year, the organisation delivered community-based support activities in the United Kingdom. These included in-person events designed to provide safe, culturally relevant spaces where individuals could access information, share lived experiences, and build peer support networks. As demand increased, the organisation extended the duration of its events to improve accessibility for attendees travelling from different parts of the UK. The organisation also expanded its reach beyond the UK through its affiliated branches in Ghana and Nigeria. These branches supported community engagement and awareness activities, helping to address gaps in knowledge, stigma, and access to information about neurological conditions in Black communities. In addition, the organisation carried out community engagement and survey work to better understand the experiences of Black individuals living with these conditions. This work identified ongoing challenges, including delays in diagnosis, lack of culturally appropriate care, and underrepresentation in research. As a result, the organisation began developing its research and advocacy work, including building partnerships and exploring initiatives to improve representation and outcomes for Black communities affected by neurological conditions. Overall, the company’s activities during the financial year have contributed to increased awareness, strengthened peer support, and improved community understanding of neurological autoimmune conditions within the populations it serves.
The company regularly consults with its key stakeholders, including patients, community members, healthcare professionals, and partner organisations. Consultation takes place through community events, direct engagement, and surveys designed to understand the experiences and needs of Black people living with neurological autoimmune conditions such as Multiple Sclerosis, NMOSD and MOGAD. Feedback from these consultations has directly informed the company’s activities. For example, increased demand for accessible and inclusive support led to the extension of community event formats to accommodate attendees travelling from different locations. Engagement with stakeholders also highlighted the need for greater awareness, culturally relevant information, and improved representation in research. In response, the company has expanded its activities to include international community engagement through its branches in Ghana and Nigeria, as well as developing its research and advocacy work to address identified gaps in care, awareness, and representation. The company will continue to use stakeholder feedback to shape its services and ensure that its activities remain responsive to the needs of the communities it serves.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
29 April 2026
And signed on behalf of the board by:
Name: Diana Natalie Busari
Status: Director